Written Question · S7W-01097 · Session 7
In light of the decentralisation of funding for diabetes technologies in April 2026, whether it will legislate to ensure that the SIGN guid…
The question
To ask the Scottish Government, in light of the decentralisation of funding for diabetes technologies in April 2026, whether it will legislate to ensure that the SIGN guideline 170, Optimising glycaemic control in people with type 1 diabetes, is adhered to.
The answer
Clinical guidelines are intended to support and inform professional clinical judgement, not to replace it. Decisions regarding any specific clinical procedure or treatment must always be made on the basis of the individual patient’s clinical condition, personal circumstances, and expressed preferences, alongside the professional judgement of the responsible healthcare team.In recognition of this principle, the Scottish Government has no plans to legislate for the mandatory use of SIGN guideline 170. Rather, the clear expectation is that GPs and other clinicians consider all relevant and applicable clinical guidelines when assessing an individual’s suitability for diabetes technologies. Access to such technologies should therefore be determined on a case-by-case basis, informed by the patient’s individual clinical needs, rather than through rigid or automatic application of any single guideline.
In the Official Report
No contribution in the Official Report cites S7W-01097 by reference.